Biotech Values

[DewDiligence]

Based on today’s Boceprevir data, I don’t think VRTX shares have fallen far enough. (Down 10% as I’m typing.)


Let’s talk biotech!
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”